Eli Lilly and (NYSE:LLY) was upgraded by Credit Suisse to an “outperform” rating in a research note issued to investors on Friday, Market Beat Ratings reports. In related news, major shareholder Lilly Endowment Inc …
Ticker Report · 11 hours ago
Shares of big pharma Eli Lilly (NYSE:LLY) rose Friday after Credit Suisse upgraded its rating on the company largely on the strength of its diabetes franchise. Analyst Vamil Divan lifted his rating on Lilly stock to …
Investors Business Daily · ByAmy Reeves · 6 hours ago
Halozyme Therapeutics (HALO): HALO stock is up 2.3% today. Eli Lilly and Company (LLY): LLY stock is up 2.6% today. Ptc Therapeutics Inc (PTCT): PTCT stock is up 2.9%, marking the third consecutive day the stock has increased. Seattle Genetics …
Investor Place · 6 hours ago
Healthcare Stocks
More from Bing News
NEW YORK (TheStreet) -- Shares of Eli Lilly (LLY - Get Report) closed down by 5.14% to $79.74 on Monday afternoon, after the company reached a settlement with healthcare company Sanofi (SNY) about patents for …
The Street · 9/28/2015
Eli Lilly & Co.'s stock LLY, +2.07% climbed 1.7% in premarket trade Friday, after the drug maker was upgraded at Credit Suisse, which said it anticipated better-than-expected sales of the diabetes drug Jardiance, sooner than originally expected.
Market Watch · ByTomi Kilgore · 9 hours ago
diabetes drug
Eli Lilly and Co. (NYSE: LLY), known as one of the powerhouses in the pharmaceutical ... ALSO READ: UBS Loves These 3 Top Biotech Stock Leaders Into Q3 Earnings Ultimately, the survey showed most physicians (especially endocrinologists) are …
24/7 Wall ST · 6 hours ago
Eli Lilly
In-depth coverage >
Eli Lilly and (NYSE:LLY) major shareholder Lilly Endowment Inc sold 260,000 shares of the stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $86.46, for a total transaction of $22,479,600.00. · 10/7/2015
Ibrance was the first CDK 4/6 inhibitor to be approved by the FDA. Both Eli Lilly and AstraZeneca are Zacks Rank #1 (Strong Buy) stocks. Another equally well-ranked stock in the health care sector is Apricus Biosciences, Inc. APRI.
NASDAQ · 44 minutes ago
Eli Lilly and Company (LLY - Analyst Report) is an Indiana-based global health ... were major revenue generators for the company before their genericization. The stock carries a Zacks Rank #2 (Buy). Wiltshire, UK-based GW Pharmaceuticals plc (GWPH ...
ZACKS · 3 hours ago
Mental Health
Eli Lilly and Co (NYSE:LLY) and Incyte Corporation (NASDAQ ... Our research has shown that hedge funds’ large-cap stock picks historically delivered a monthly alpha of six basis points, though these stocks …
INSIDER MONKEY · 9/30/2015
Hedge Funds

Eli Lilly and Company

Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in t…
Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries. Their products are sold in approximately 125 countries. The company was founded in 1876 by Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War, after whom the company was named.
Data from: Wikipedia · Freebase